Linda P T Joosten

5PUBLICATIONS
12CO-AUTHORS
Haematological tumoursMolecular targetsCardiology (incl. cardiovascular diseases)Traditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2023
Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.

Linda P T Joosten, Sander van Doorn, Peter M van de Ven

|May 11, 2023
Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis.

Linda P T Joosten, Rosanne van Maanen, Carline J van den Dries

|Apr 11, 2022
Cardiovascular vulnerability predicts hospitalisation in primary care clinically suspected and confirmed COVID-19 patients: A model development and validation study.

Florien S van Royen, Linda P T Joosten, Maarten van Smeden

|Mar 01, 2022
Atrial fibrillation: trends in prevalence and antithrombotic prescriptions in the community.

L P T Joosten, A R de Boer, E J B van Eerde

|Jan 01, 2020
Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial.

Linda P T Joosten, Sander van Doorn, Arno W Hoes

Pageof 1

Frequent Collaborators

3 joint publications

Sander van Doorn

1 joint publications

Florien S van Royen

1 joint publications

Peter M van de Ven

1 joint publications

Melchior C Nierman